Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMSCT in Asherman's Syndrome and Endometrial Atrophy
NCT02144987Phase 4Completed
- Sponsor
- IVI
- Start
- Apr 2013
- Primary completion
- Sep 2014
- Countries
- 1
01
Overview
A Phase 4 trial of autologous CD133+ cells in Asherman's syndrome (AS), endometrial atrophy, sponsored by IVI. Started Apr 2013; status: completed.
02
Drugs
autologous CD133+ cells
03
Conditions
Asherman's syndrome (AS)endometrial atrophy
Beyond the preview
Go deeper on NCT02144987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144987.